Gene Therapy-Mediated Modulation of Immune Processes in the Central Nervous System

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|9|24|2002-2008

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.24, 2003-09, pp. : 2002-2008

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene Therapy Targeting in the Central Nervous System

By  

Current Gene Therapy, Vol. 3, Iss. 2, 2003-04 ,pp. : 127-145

Bentham Science Publishers

Access to resources Recommend Favorite

Liposomal and Viral Vectors for Gene Therapy of the Central Nervous System

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 4, 2005-08 ,pp. : 453-465

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Immune Cells in the Course of Central Nervous System Injury: Modulation with Natural Products

By  

Current Pharmaceutical Design, Vol. 22, Iss. 6, 2016-02 ,pp. : 701-708

Bentham Science Publishers

Access to resources Recommend Favorite

Animal Models of Central Nervous System Immune-Mediated Diseases: Therapeutic Interventions with Bioactive Peptides and Mimetics

By  

Current Medicinal Chemistry, Vol. 12, Iss. 13, 2005-06 ,pp. : 1513-1519

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of Innate Immune Responses in the Central Nervous System

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 1, 2011-02 ,pp. : 4-24

Bentham Science Publishers

Access to resources Recommend Favorite